Low Number Of Device Inspections Attributable To Tight Budget, QSR
This article was originally published in The Gray Sheet
FDA's device facility inspections are expected to remain at the relatively low number of 3,196 in fiscal year 1998 given the decreased FDA budget allocations and the learning curve associated with the new design controls portion of the quality systems regulation.
You may also be interested in...
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.